Influential scientific researchers in the ME/CFS community will come together this Saturday, Aug. 12 for a one-day community symposium focused on the molecular basis of ME/CFS at Stanford University Palo Alto, California.
Register here to join the livestream and be part of the conversation. View the agenda here. (DVDs can also be ordered for $15 from the Open Medicine Foundation.)
The symposium will be held from 9 a.m. to 5 p.m. PST, (California time). The event follows a two-day meeting of the the world-renowned scientists sponsored by the Open Medicine Foundation.
“To date we have been able to develop a potential diagnostic and treatment screening assay using our new nanofabricated device on a few patients and healthy controls,” wrote Ronald W. Davis, PhD in a welcome letter to the symposium. Davis is director of the Stanford Genome Technology Center and director of the Chronic Fatigue Syndrome Research Center at Stanford University. “We have also generated a large amount of molecular data on a few patients, which has pointed to pathways that should help us understand the disease. Our collaborative team meeting will allow for in-depth scientific discussion of ME/CFS research results, and for strategizing on the best way forward for the scientific community.
“At the Community Symposium, the scientists will update patients and any interested members of the public on our progress towards understanding the molecular basis of ME/CFS and our plans for the future.
Only together can we solve this incredibly complex and horrific disease.”
It has come to light that a letter from NHS England and NHS Improvement to all vaccination centres and GPs in the UK has omitted advice that health professionals can and should apply their clinical judgement when placing people in group 6. Vaccination of people with underlying health conditions that put them at risk of